|
KLHDC10 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.028820E-01 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
6.656000E-02 |
| Normal-vs-Stage2 |
5.981600E-01 |
| Normal-vs-Stage3 |
6.143900E-02 |
| Normal-vs-Stage4 |
9.719800E-03 |
| Stage1-vs-Stage2 |
3.306400E-01 |
| Stage1-vs-Stage3 |
6.266200E-01 |
| Stage1-vs-Stage4 |
4.763200E-01 |
| Stage2-vs-Stage3 |
2.494200E-01 |
| Stage2-vs-Stage4 |
1.695570E-01 |
| Stage3-vs-Stage4 |
6.257800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
7.524200E-02 |
| Normal-vs-AfricanAmerican |
5.016000E-01 |
| Normal-vs-Asian |
6.762400E-02 |
| Caucasian-vs-AfricanAmerican |
7.827400E-01 |
| Caucasian-vs-Asian |
6.530600E-01 |
| AfricanAmerican-vs-Asian |
6.769200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
3.420900E-03 |
| Normal-vs-Female |
3.193400E-01 |
| Male-vs-Female |
1.151790E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
4.244100E-02 |
| Normal-vs-Extreme_Weight |
1.654270E-02 |
| Normal-vs-Obese |
9.147000E-01 |
| Normal-vs-Extreme_Obese |
3.749200E-01 |
| Normal_Weight-vs-Extreme_Weight |
8.933600E-01 |
| Normal_Weight-vs-Obese |
1.205200E-01 |
| Normal_Weight-vs-Extreme_Obese |
8.787000E-01 |
| Extreme_Weight-vs-Obese |
7.325700E-02 |
| Extreme_Weight-vs-Extreme_Obese |
8.359200E-01 |
| Obese-vs-Extreme_Obese |
4.991200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
3.341200E-01 |
| Normal-vs-Age(41-60Yrs) |
8.621600E-01 |
| Normal-vs-Age(61-80Yrs) |
2.267700E-02 |
| Normal-vs-Age(81-100Yrs) |
1.228590E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
4.239400E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
5.599600E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
4.195200E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
6.272300E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
2.265200E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
7.342600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
3.082400E-01 |
| Normal-VS-Type2 PRCC |
1.591890E-02 |
| Normal-VS-KIRP CIMP |
8.225800E-01 |
| Normal-VS-Unclassified PRCC |
8.741000E-01 |
| Type1 PRCC-VS-Type2 PRCC |
1.708430E-01 |
| Type1 PRCC-VS-KIRP CIMP |
8.701400E-01 |
| Type1 PRCC-VS-Unclassified PRCC |
6.790400E-01 |
| Type2 PRCC-VS-KIRP CIMP |
3.840000E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
1.502630E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
9.369800E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
6.188300E-04 |
| Normal-vs-N1 |
6.672000E-02 |
| Normal-vs-N2 |
1.525360E-01 |
| N0-vs-N1 |
4.228400E-01 |
| N0-vs-N2 |
7.843400E-01 |
| N1-vs-N2 |
9.166000E-01 |
|
|
